Vanguard Is "Cautious" on U.S. Growth Stocks. These 2 Value ETFs Could Be Smarter Buys for Long-Term Investors.

Vanguard’s 10-year outlook (published July 22) argues U.S. value stocks should outperform U.S. growth, forecasting average annual returns of 6.4%–8.4% for value vs 3.6%–5.6% for growth. The article links this to concerns that AI-driven growth stocks are “already stretched” on valuation and that AI upside may already be priced in. It highlights ETF performance as context: VFVA value factor returned 12.4% annualized over five years and 35.4% over the past year, while VBR small-cap value returned 9.75% annualized over five years and 25.75% over the past year.

Analysis

This is best viewed as a factor-regime setup, not a single-name event. If market leadership narrows and investors start demanding proof that AI capex is translating into incremental free cash flow, the cheapest balance-sheet-adjusted earnings streams should re-rate first, especially in financials, industrials, energy, and select health care. The second-order effect is that AI can be bullish for value not because tech breaks, but because productivity gains widen margins outside tech faster than sell-side models assume.

The immediate risk is timing: in the next few weeks, momentum can keep beating fundamentals if mega-cap AI spend stays the dominant narrative. Over 1-3 months, the key catalyst is breadth—if earnings revisions start rising for cyclicals and domestically exposed small caps, factor flows can rotate quickly out of crowded growth. Over 6-18 months, the larger issue is whether higher-for-longer rates keep compressing long-duration multiples; if they do, small-cap value has a much cleaner path than expensive growth.

Within the named complex, EOG is the cleanest quality/value expression because it has direct cash-flow sensitivity and less dependence on multiple expansion. BMY/PFE are more of a defensive pair than a growth call; their upside comes from low expectations and dividend support, not explosive operating leverage. GM and WSM are higher-beta value exposure to easing financial conditions, but they are the first to break if consumer credit deteriorates; INTU is the best example of a 'quality value' name that can benefit if enterprise spend broadens beyond megacap tech.

Consensus may be missing that this is not necessarily anti-AI; if AI productivity spills into non-tech sectors, value can be the bigger beneficiary than the hyperscalers. The thesis is falsified if AI monetization keeps accelerating faster than capex growth, or if 10Y yields fall enough to extend duration multiples and re-ignite growth leadership.

Key Decisions for Investors

• Go long VBR vs short IWF or QQQ for a 3-6 month factor-rotation trade; target 5-8% relative outperformance if breadth improves and rates stay sticky.
• Add EOG on weakness as the cleanest low-multiple, cash-flow-backed value expression; thesis breaks if crude weakens materially or E&P FCF guidance rolls over.
• Prefer INTU and BMY over the more cyclical value names inside VFVA/VBR; these are lower-beta ways to own the rotation without needing a hard macro landing.
• Avoid chasing GM/WSM here unless credit spreads stabilize; use them only as higher-beta longs if the next CPI/Fed path supports easier financial conditions.
• Set a watch alert on XLK/QQQ relative to VBR: if growth regains leadership after the next earnings cycle, cut the rotation trade rather than averaging down.